Similar articles for PMID: 28885911

Year	Number of Results
2010	2
2011	4
2012	3
2013	11
2014	36
2015	29
2016	21
2017	19
2018	6
2019	6
2020	7
2021	0

1

Renal denervation: What happened, and why?

Shishehbor MH, Hammad TA, Thomas G. Shishehbor MH, et al. Cleve Clin J Med. 2017 Sep;84(9):681-686. doi: 10.3949/ccjm.84a.14129. Cleve Clin J Med. 2017. PMID: 28885911 Free article. Review.

2

Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.

Esler M. Esler M. J Am Soc Hypertens. 2014 Aug;8(8):593-8. doi: 10.1016/j.jash.2014.06.001. Epub 2014 Jun 12. J Am Soc Hypertens. 2014. PMID: 25151320 Review.

3

[New opportunities of renal denervation].

Agaeva RA, Danilov NM, Shelkova GV, Matchin YG, Chazova IE. Agaeva RA, et al. Ter Arkh. 2020 Jul 9;92(6):84-88. doi: 10.26442/00403660.2020.06.000588. Ter Arkh. 2020. PMID: 33346499 Russian.

4

Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.

Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP. Esler MD, et al. Eur Heart J. 2014 Jul;35(26):1752-9. doi: 10.1093/eurheartj/ehu209. Epub 2014 Jun 4. Eur Heart J. 2014. PMID: 24898552 Free PMC article. Clinical Trial.

5

12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.

Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators. Bakris GL, et al. J Am Coll Cardiol. 2015 Apr 7;65(13):1314-1321. doi: 10.1016/j.jacc.2015.01.037. J Am Coll Cardiol. 2015. PMID: 25835443 Free article. Clinical Trial.

6

Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?

Epstein M, de Marchena E. Epstein M, et al. J Am Soc Hypertens. 2015 Feb;9(2):140-9. doi: 10.1016/j.jash.2014.12.002. Epub 2014 Dec 11. J Am Soc Hypertens. 2015. PMID: 25649995 Review.

7

Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.

Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators. Bakris GL, et al. J Am Coll Cardiol. 2014 Sep 16;64(11):1071-8. doi: 10.1016/j.jacc.2014.05.012. Epub 2014 May 20. J Am Coll Cardiol. 2014. PMID: 24858423 Free article. Clinical Trial.

8

Percutaneous renal sympathetic denervation: 2013 and beyond.

Froeschl M, Hadziomerovic A, Ruzicka M. Froeschl M, et al. Can J Cardiol. 2014 Jan;30(1):64-74. doi: 10.1016/j.cjca.2013.11.003. Epub 2013 Nov 7. Can J Cardiol. 2014. PMID: 24365191 Review.

9

[Position paper on the results of Symplicity HTN-3 trial. Grupo de estudio de la hipertensión arterial resistente].

Azpiri-López JR, Assad-Morell JL, Ponce de León-Martínez E, Monreal-Puente R, Dávila-Bortoni A, Vázquez-Díaz LA, Treviño-Frutos RJ, Barrera-Oranday F, Del Angel-Soto JG, Martínez JG, Arellano-Torres M. Azpiri-López JR, et al. Arch Cardiol Mex. 2015 Apr-Jun;85(2):154-7. doi: 10.1016/j.acmx.2014.11.007. Epub 2015 Feb 18. Arch Cardiol Mex. 2015. PMID: 25700579 Spanish.

10

Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.

Kario K, Bhatt DL, Brar S, Cohen SA, Fahy M, Bakris GL. Kario K, et al. Hypertension. 2015 Dec;66(6):1130-7. doi: 10.1161/HYPERTENSIONAHA.115.06260. Epub 2015 Oct 5. Hypertension. 2015. PMID: 26558819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed